Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases

Objectives: Neuropilin 1 (NRP1) is a transmembrane protein with diverse roles in physiological and pathological settings. NRP1 expression has been reported on T cells in inflammatory microenvironments and in secondary lymphoid tissue. Tumor-infiltrating lymphocytes (TILs) play an important role in cancer prognosis. In this study, we investigated NRP1 expression on TILs and peripheral blood mononuclear cells (PBMCs) from colorectal cancer liver metastases (LI/CRC). Methods: TILs from LI/CRC and PBMCs from healthy donors and patients were analyzed for expression of NRP1, in addition to other Treg-related markers. PBMCs were co-cultured in vitro with tumor tissue and analyzed for NRP1 expression. Results: We report for the first time that NRP1 is highly expressed on CD3+CD4+ TILs compared to PBMCs. NRP1 expression correlated closely with CD25 expression in TILs. NRP1 was expressed on both Helios+ and Helios– FoxP3-expressing Tregs and on a FoxP3–Helios– T cell subset. It was also induced on PBMCs following in vitro co-culture with tumor tissue. Conclusions: NRP1 is upregulated on TILs and can be induced on PBMCs by tumor tissue. Further studies are warranted to define the function of NRP1 on human TILs. As a therapeutic target, NRP1 may allow selective targeting of TIL subsets including suppressive Tregs.

[1]  E. Elkord,et al.  Helios expression in FoxP3+ T regulatory cells , 2012, Expert opinion on biological therapy.

[2]  Tianjiao Ji,et al.  Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment. , 2014, ACS nano.

[3]  S. Sengupta,et al.  Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors. , 2011, Neuro-oncology.

[4]  L. Bullinger,et al.  The VEGF receptor, neuropilin‐1, represents a promising novel target for chronic lymphocytic leukemia patients , 2013, International Journal of Cancer.

[5]  E. Elkord.  Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation. , 2009, Journal of immunological methods.

[6]  J. Allison,et al.  Expression of Helios in Peripherally Induced Foxp3+ Regulatory T Cells , 2012, The Journal of Immunology.

[7]  P. Hegde,et al.  Pharmacokinetic and Pharmacodynamic Analysis of Circulating Biomarkers of Anti-NRP1, a Novel Antiangiogenesis Agent, in Two Phase I Trials in Patients with Advanced Solid Tumors , 2012, Clinical Cancer Research.

[8]  Chun Xing Li,et al.  Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node. , 2013, Pathology, research and practice.

[9]  Shenmin Zhang,et al.  Distribution of regulatory T cells and interaction with dendritic cells in the synovium of rheumatoid arthritis , 2012, Scandinavian journal of rheumatology.

[10]  S. Soker,et al.  Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Dong Hairong,et al.  Gene Expression of Neuropilin-1 and Its Receptors, VEGF/Semaphorin 3a, in Normal and Cancer Cells , 2010, Cell Biochemistry and Biophysics.

[12]  J. Karbach,et al.  Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans , 2013, Proceedings of the National Academy of Sciences.

[13]  K. Ladell,et al.  Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells , 2013, Mucosal Immunology.

[14]  F. Lemonnier,et al.  Neuropilin-1 Expression Characterizes T Follicular Helper (Tfh) Cells Activated during B Cell Differentiation in Human Secondary Lymphoid Organs , 2013, PloS one.

[15]  M. Montès,et al.  Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model. , 2014, Cancer letters.

[16]  Katherine W Ferrara,et al.  Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[17]  M. Mazzone,et al.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. , 2013, Cancer cell.

[18]  D. Valmori,et al.  Human Memory Helios− FOXP3+ Regulatory T Cells (Tregs) Encompass Induced Tregs That Express Aiolos and Respond to IL-1β by Downregulating Their Suppressor Functions , 2013, The Journal of Immunology.

[19]  W. Hansen.  Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma , 2013, Oncoimmunology.

[20]  J. Weiss,et al.  Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells , 2012, The Journal of experimental medicine.

[21]  P. Price,et al.  Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV‐infected patients responding to antiretroviral therapy , 2006, Immunology and cell biology.

[22]  E. Macintyre,et al.  Neuropilin‐1 is not a marker of human Foxp3+ Treg , 2009, European journal of immunology.

[23]  T. Shin,et al.  Enhancement of the Tumor Penetration of Monoclonal Antibody by Fusion of a Neuropilin-Targeting Peptide Improves the Antitumor Efficacy , 2014, Molecular Cancer Therapeutics.

[24]  Judy Mak,et al.  Neuropilin‐1 expression in cancer and development , 2012, The Journal of pathology.

[25]  T. Whiteside.  Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? , 2013, Cancer Immunology, Immunotherapy.

[26]  A. Fattorossi,et al.  Neuropilin‐1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer , 2008, Immunology.

[27]  A. Fattorossi,et al.  Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer. , 2010, International journal of radiation oncology, biology, physics.

[28]  M. Reed,et al.  Neuropilin‐1 and neuropilin‐2 expression in the adenoma–carcinoma sequence of colorectal cancer , 2013, Histopathology.

[29]  Olivier Hermine,et al.  A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response , 2002, Nature Immunology.

[30]  P. Romeo,et al.  Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer1 , 2006, The Journal of Immunology.

[31]  D. Finkelstein,et al.  Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis , 2013, Nature.

[32]  D. Schadendorf,et al.  Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth , 2012, The Journal of experimental medicine.

[33]  B. Shalmon,et al.  Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy , 2011, Journal of immunotherapy.

[34]  S. Rosenberg,et al.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.

[35]  D. Burt,et al.  Expanded subpopulation of FoxP3+ T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs. , 2011, Clinical immunology.

[36]  E. Elkord.  Comment on “Expression of Helios in Peripherally Induced Foxp3+ Regulatory T Cells” , 2012, The Journal of Immunology.

[37]  K. Okawa,et al.  Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. , 2002, Human immunology.

[38]  U. Beier,et al.  Helios Expression Is a Marker of T Cell Activation and Proliferation , 2011, PloS one.

[39]  G. Scott,et al.  Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent , 2012, PloS one.

[40]  B. Ammori,et al.  Neuropilin 1: function and therapeutic potential in cancer , 2014, Cancer Immunology, Immunotherapy.

[41]  E. Elkord,et al.  Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer , 2014, Expert opinion on biological therapy.

[42]  R. Sellers,et al.  Helios Induces Epigenetic Silencing of Il2 Gene Expression in Regulatory T Cells , 2013, The Journal of Immunology.

[43]  Y. Glinka,et al.  Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. , 2011, Carcinogenesis.

[44]  G. Kang,et al.  Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. , 2014, Human pathology.

[45]  S. Rosenberg,et al.  Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.

[46]  Michael R. Green,et al.  Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. , 2013, The Journal of clinical investigation.

[47]  D. Getnet,et al.  Phenotypic and Functional Properties of Helios+ Regulatory T Cells , 2012, PloS one.

[48]  B. Schilling,et al.  Induced and natural regulatory T cells in human cancer , 2012, Expert opinion on biological therapy.

[49]  M. Tessier-Lavigne,et al.  Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. , 2007, Journal of molecular biology.

[50]  J. Bluestone,et al.  Peripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity , 2013, Front. Immunol..

[51]  A. Fattorossi,et al.  Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer , 2009, Cancer Immunology, Immunotherapy.

[52]  A. G. Betz,et al.  Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition , 2008, Immunity.

[53]  Shimon Sakaguchi,et al.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. , 2006, International immunology.

[54]  A. Catalano.  The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis , 2010, The Journal of Immunology.

[55]  Daniel J. Kuster,et al.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo , 2012, The Journal of experimental medicine.

[56]  I. Zachary,et al.  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity , 2010, British Journal of Cancer.